-+ 0.00%
-+ 0.00%
-+ 0.00%

Vyome Therapeutics Sets Board To Lead Reshape Lifesciences Post-Close; New Entity To Trade As Vyome Holdings Under Ticker Symbol HIND

Benzinga·08/12/2025 13:55:53
Listen to the news

Heavily shareholder-aligned board and management team completely replaces ReShape team as Vyome prepares for public listing on August 15, 2025

Vyome Therapeutics, Inc., a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases in the US and global markets with large market potential, today announced its post-closing Board of Directors, expected to take control of the ReShape Lifesciences (NASDAQ:RSLS) public entity on Friday, August 15, 2025, which will be renamed Vyome Holdings, Inc. post-closing and trade under the ticker symbol HIND.

The new Vyome board members, which include four Massachusetts Institute of Technology (MIT) alums, are all persons with prior board or executive management experience and are based in the US while having deep ties to the Indian subcontinent and the latest advances in AI.